DexCom, Inc.
DXCM
Pozycja w akcjach
#758
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Cena akcji
$85.98
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$32.45B
Zmiana (1 dzień)
-1.97%
Zmiana (1 rok)
29.10%
Kraj
US
Handel DexCom, Inc. (DXCM)
Kategoria
Healthcare
Marża operacyjna dla DexCom, Inc. (DXCM)
Marża operacyjna na dzień October 2026 TTM: 22.92%
Według najnowszych raportów finansowych i ceny akcji DexCom, Inc., bieżąca marża operacyjna (TTM) wynosi 22.92%. Na koniec 2023 wynosiła 16.50%.
Historia marży operacyjnej dla DexCom, Inc. od 2000 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 22.92% | 54.03% |
| 2024 | 14.88% | -9.82% |
| 2023 | 16.50% | 22.77% |
| 2022 | 13.44% | 23.76% |
| 2021 | 10.86% | -30.12% |
| 2020 | 15.54% | 61.20% |
| 2019 | 9.64% | -153.38% |
| 2018 | -18.06% | 205.07% |
| 2017 | -5.92% | -46.91% |
| 2016 | -11.15% | -21.48% |
| 2015 | -14.20% | 71.29% |
| 2014 | -8.29% | -54.10% |
| 2013 | -18.06% | -67.61% |
| 2012 | -55.76% | -5.17% |
| 2011 | -58.80% | -36.86% |
| 2010 | -93.13% | -39.67% |
| 2009 | -154.36% | -71.25% |
| 2008 | -536.97% | -46.77% |
| 2007 | -1,008.77% | -55.62% |
| 2006 | -2,273.03% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 17.03% | -99.26% |
US
|
|
| 17.86% | -99.22% |
IE
|
|
| 22.03% | -99.04% |
US
|
|
| 21.46% | -99.06% |
US
|
|
| 0.00% | - |
DE
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.